Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
07/2004
07/07/2004EP1434863A1 IDENTIFICATION AND USE OF MAMMALIAN p21 INHIBITORS
07/07/2004EP1434862A2 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns
07/07/2004EP1434858A1 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
07/07/2004EP1434789A2 Improved protein disaggregation and refolding using high pressure
07/07/2004EP1232249B1 Duck pneumovirus and corresponding vaccines
07/07/2004CN1511190A Composition and methods useful for HCV infection
07/07/2004CN1510130A Attenuated cattle viral diarrhoea virus
07/07/2004CN1510129A Structure for recombinant adenovirus with double killer function and application in tumor treatment
07/07/2004CN1509764A Preparation of target gene virus medicine against cancers
07/06/2004US6759231 Kit for in transform and expression of heterologous gene in bacterial
07/06/2004US6759229 Contacting a bacterial cell lysogenic for the selected bacteriophage genome with the isolated nucleic acid molecule such that the isolated nucleic acid is introduced into the bacterial cell; allowing it to recombine with genome
07/01/2004WO2004055216A2 Replication of hepatitis c virus in non-hepatic epithelial and mouse hepatic cells
07/01/2004WO2004055167A2 Alphavirus particles and methods for preparation
07/01/2004WO2004055166A2 Multi-antigenic alphavirus replicon particles and methods
07/01/2004WO2004055161A2 Large scale production of packaged alphavirus replicons
07/01/2004WO2004054613A1 A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
07/01/2004WO2004020600A3 Modified aav
07/01/2004WO2004011489A3 Tropism-modified adenoviral vectors, preferably for targeting b-lymphocytes or ovarian cells
07/01/2004WO2003092582A3 Chimeric ebola virus envelopes and uses therefor
07/01/2004WO2003091386A3 A new family of picornaviruses
07/01/2004US20040126880 Using gamma radiation to inactivate, decrease and/or remove contaminants associated with functioning biological materials, biochemical entities and biologically active molecules and storing materials at room temperature
07/01/2004US20040126869 Method of producing infectious reovirus
07/01/2004US20040126753 Process for producing viral rna polymerase
07/01/2004US20040126388 Measurement genome reproduction of virus; linked to reproter compound; high speed screening for Hepatitis virus
07/01/2004CA2840513A1 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
07/01/2004CA2807515A1 Alphavirus particles and methods for preparation
07/01/2004CA2510227A1 A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
07/01/2004CA2509979A1 Alphavirus particles and methods for preparation
07/01/2004CA2509973A1 Multi-antigenic alphavirus replicon particles and methods
06/2004
06/30/2004EP1433851A2 Improved expression of HIV polypeptides and production of virus-like particles
06/30/2004EP1433846A2 Phagemid-based method of producing filamentous bacteriophage particles displaying antibody molecules and the corresponding bacteriophage particles.
06/30/2004EP1433483A1 Reovirus for the treatment of neoplasia wherein double stranded RNA-activated protein kinase (PKR) is inactivated or deleted
06/30/2004EP1432791A1 Alphavirus replicon vector systems
06/30/2004EP1169063B1 Treatment of intracellular infection
06/30/2004EP1007637B1 Methods for increasing the efficiency of recombinant aav product
06/30/2004EP1002055B1 Recovery of virus from cell culture using a hypertonic salt solution
06/30/2004EP0724643B1 Endosomolytically active particles
06/30/2004CN1155710C Recombinant herpesvirus with the use of gB Gene promoter
06/29/2004US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain
06/29/2004US6756203 Assays for compounds that modulate rhadino virus LANA action in trans on a unit of rhadino virus DNA to mediate efficient episome persistence
06/29/2004US6756198 Nucleotide sequences for use in the treatment of and prevention of viral infections
06/29/2004US6756044 Heightening response of immune effector cells
06/24/2004WO2004053115A1 Magnetism based rapid cell separation
06/24/2004WO2004052278A2 Escape mutants of newcastle disease virus as marker vaccines
06/24/2004WO2004052274A2 Production of bacteriophage compositions for use in phage therapy
06/24/2004WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof
06/24/2004WO2003093461A8 Genomic library of cyanophage s-2l and functional analysis
06/24/2004WO2003072716A3 Sequence analysis of the tetravalent rotavirus vaccine
06/24/2004US20040121976 Anti-inflammatory vectors
06/24/2004US20040121466 Alphavirus RNA replicon systems
06/24/2004US20040121465 Optimization of gene sequences of virus-like particles for expression in insect cells
06/24/2004US20040121444 Method of preparing recombinant adeno-associated virus compositions
06/24/2004US20040120972 equine abortion virus mutant
06/24/2004US20040120969 The pure isolate does not suffer from the disadvantages of potential batch to batch variation between substrains and provides a product which is easier to ensure will meet consistent quality guidelines
06/24/2004US20040120929 Defective lentivirus pseudotyped with a lyssavirus envelope; selective transfer of genes into astrocytes of central nervous system; nervous system and brain disorders; viral diseases
06/24/2004CA2507592A1 Magnetism based rapid cell separation
06/23/2004EP1430137A2 Porcine adenovirus e1 and e4 regions
06/23/2004EP1430127A1 Polynucleotide fragments of an infectious human endogenous retrovirus
06/23/2004CN1506460A Method and kit for separating cell particle from sample
06/23/2004CN1154744C Retroviral vectors that containing none of viral coding sequences
06/23/2004CN1154743C Amphotropic retrovirus packaging cell line, process for its production and use thereof
06/23/2004CN1154742C Recombinant MVA virus, and the use thereof
06/22/2004US6753136 Expressing preferential amino acid sequences on surface of viruses; obtain genetically engineered viruses, express amino acid sequences, moniltor viral coat for presence of preferential amino acid sequences
06/22/2004CA2110702C Process for the production of a viable cell culture infected by a multiple sclerosis associated virus
06/17/2004WO2004050843A2 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making
06/17/2004WO2004050829A2 Recombinant double-stranded rna phage, and use of the same
06/17/2004WO2004050680A2 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
06/17/2004WO2004011677A3 Viral marker
06/17/2004US20040116660 Identifying lymphadenopathy associated viral variants and using sequence homologies in envelope proteins to generate concensus sequence for use in developing vaccine aganist infection; immunotherapy; viricides
06/17/2004US20040116368 Methods for detecting and adjusting replication of hepatitis b virus and for preparing mutated virus strains with altered replication efficiency
06/17/2004US20040115788 Hybrid adeno-retroviral vector for the transfection of cells
06/17/2004US20040115170 reducing viability of a tumor cell by administering a non-naturally occuring reovirus expressing a particular mu-2 protein or a virus capable of expressing the reovirus mu-2 protein
06/17/2004CA2508378A1 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making
06/17/2004CA2485341A1 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
06/16/2004EP1428887A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells
06/16/2004EP1428886A1 Improved retroviral vectors for gene therapy
06/16/2004EP1427836A2 Pseudotyped retroviral vector system
06/16/2004EP1427835A1 Method for purification of viral vectors having proteins which bind sialic acid
06/16/2004EP1427823A2 High throughput directed evolution by rational mutagenesis
06/16/2004EP1427817A1 Multiplication of viruses in a cell culture
06/16/2004EP1427816A1 Site-specific recombinase based method for producing adenoviral vectors
06/16/2004EP1427815A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
06/16/2004EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
06/16/2004EP1427752A2 New hepatitis c virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
06/16/2004EP1427444A2 West nile vaccine
06/16/2004EP0789563B1 Hepatitis virus b and c vaccines
06/16/2004EP0580737B1 Heterodimeric receptor libraries using phagemids
06/16/2004CN1504566A Immunology epitope of hog cholera virus feature and application thereof
06/15/2004US6750043 Expression vector for use in the expression of heterologous protein in cells
06/15/2004US6750009 Multiple viral replicon culture systems
06/15/2004US6749857 Recombinant dimeric envelope vaccine against flaviviral infection
06/10/2004WO2004048543A2 Methods and compositions for controlling valency of phage display
06/10/2004WO2004048402A2 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene
06/10/2004WO2004047812A1 Hollow nanoparticles of protein and drug using the same
06/10/2004WO2004037202A9 Gb virus c and methods of treating viral infections
06/10/2004WO2004032959A3 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
06/10/2004US20040110269 Protection against mycobacterial infections
06/10/2004US20040110266 Using high performance liquid chromatography to isolate adeno-associated virus particles from cultures; genetic engineering and gene transfer tools
06/10/2004US20040109877 Rna viruses; attenuation influenza virus
06/10/2004US20040109873 Genetic engineering equine herpes virus; genes coding protein